XBiotech Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -131.0% | -274.9% | – | – | – | -775.1% | – | – | – | – | – | – | |
| – | 16.6% | 16.5% | – | – | – | 51.0% | – | – | – | – | – | – | |
| – | 26.3% | 14.5% | – | – | – | 384.0% | – | – | – | – | – | – | |
| – | 50.6% | 15.5% | – | – | – | 78.1% | – | – | – | – | – | – | |
| – | 4.4% | 9.7% | – | – | – | 10.8% | – | – | – | – | – | – | |
| – | -4.4% | -9.7% | – | – | – | -10.8% | – | – | – | – | – | – | |
| – | – | – | – | – | – | -1,182.2% | – | – | – | – | – | – | |
| – | -351.9% | 383.8% | – | – | – | -1,182.2% | – | – | – | – | – | – | |
| – | -82.7% | 38.8% | – | – | – | -1,935.4% | – | – | – | – | – | – | |
| – | -135.4% | -284.6% | – | – | – | -785.9% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.